Concepedia

Myricetin possesses the potency against SARS-CoV-2 infection through blocking viral-entry facilitators and suppressing inflammation in rats and mice

Hudan Pan, Jinlian He, Zifeng Yang, Xiaojun Yao, Han Zhang, Runfeng Li, Runfeng Li, Yao Xiao, Zhao CaiPing, Haiming Jiang,

Phytomedicine · 2023 · 36 citations · 26 references

DOIFull text

Open access

Concepts

References

26

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder et al. · Cell · 2020 · 21.4K citations · Full text

, , +11

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls, Young‐Jun Park, M. Alejandra Tortorici et al. · Cell · 2020 · 9.1K citations · Full text

, , +10

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

Bin Cao, Yeming Wang, Danning Wen et al. · New England Journal of Medicine · 2020 · 5.5K citations · Full text

, , +15

An inflammatory cytokine signature predicts COVID-19 severity and survival

Diane M. Del Valle, Seunghee Kim‐Schulze, Hsin-Hui Huang et al. · Nature Medicine · 2020 · 2.7K citations · Full text

, , +14

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Carolina Lucas, Patrick Wong, Jon Klein et al. · Nature · 2020 · 2.3K citations · Full text

, , +16